Pregled bibliografske jedinice broj: 726810
TANIA: A randomized phase III trial evaluating continued and reintroduced bevacizumab in patients previously treated with first-line bevacizumab for locally recurrent/metastatic breast cancer
TANIA: A randomized phase III trial evaluating continued and reintroduced bevacizumab in patients previously treated with first-line bevacizumab for locally recurrent/metastatic breast cancer // ESMO
Španjolska, 2012. (poster, nije recenziran, sažetak, znanstveni)
CROSBI ID: 726810 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
TANIA: A randomized phase III trial evaluating continued and reintroduced bevacizumab in patients previously treated with first-line bevacizumab for locally recurrent/metastatic breast cancer
Autori
Von Minckwitz, G ; Cortes, J ; Gligorov, J ; Marschner, N ; Puglisi, F ; Vrdoljak, e ; Duenne, A ; Zielinski, C ;
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Skup
ESMO
Mjesto i datum
Španjolska, 2012
Vrsta sudjelovanja
Poster
Vrsta recenzije
Nije recenziran
Ključne riječi
metastatic breast cancer
Sažetak
A randomized phase III trial evaluating continued and reintroduced bevacizumab in patients previously treated with first-line bevacizumab for locally recurrent/metastatic breast cancer
Izvorni jezik
Engleski
